CS214514B1 - Method of making the /3a alpha,4beta,6a alpha/hexahydro-5-acyloxy-4-carboxy-2h-cyclopenta/b/ furran-2-on - Google Patents
Method of making the /3a alpha,4beta,6a alpha/hexahydro-5-acyloxy-4-carboxy-2h-cyclopenta/b/ furran-2-on Download PDFInfo
- Publication number
- CS214514B1 CS214514B1 CS508980A CS508980A CS214514B1 CS 214514 B1 CS214514 B1 CS 214514B1 CS 508980 A CS508980 A CS 508980A CS 508980 A CS508980 A CS 508980A CS 214514 B1 CS214514 B1 CS 214514B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- acid
- carboxy
- alpha
- treatment
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 14
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims description 4
- 239000012346 acetyl chloride Substances 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 238000005904 alkaline hydrolysis reaction Methods 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 150000004965 peroxy acids Chemical class 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 235000011054 acetic acid Nutrition 0.000 claims 2
- BUBVLQDEIIUIQG-UHFFFAOYSA-N 3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-one Chemical compound C=1C=CC=CC=1COC1C(OCC=2C=CC=CC=2)C(OCC=2C=CC=CC=2)C(=O)OC1COCC1=CC=CC=C1 BUBVLQDEIIUIQG-UHFFFAOYSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 150000001243 acetic acids Chemical class 0.000 claims 1
- 239000012670 alkaline solution Substances 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- -1 peroxy compound Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- 150000002148 esters Chemical group 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KFUSEUYYWQURPO-UHFFFAOYSA-N 1,2-dichloroethene Chemical compound ClC=CCl KFUSEUYYWQURPO-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- POKRQUNDSGAZIA-OALUTQOASA-N 7-[(1r,2s)-2-octylcyclopentyl]hepta-2,4-dienoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCC=CC=CC(O)=O POKRQUNDSGAZIA-OALUTQOASA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Vynález ae týká způsobu výroby /3aaC , 4(2» , 5oč , 6a oč. /hexahydro-5-acyloxy-4-karboxý-2H-cyklopenta QbJ fttran-2-onu obecného vzorce I,The invention relates to a process for the preparation of (3aaC, 4 (2 ', 5a, 6a)) hexahydro-5-acyloxy-4-carboxy-2H-cyclopenta-QbJ-pyran-2-one of formula I,
kde R^ značí alkyl a 1 až 3 atomy uhlíku, který je významným meziproduktem při syntéze derivátů prostadienové kyseliny označovaných Jako prostaglandlny. Vysoká biologickéwherein R 1 represents alkyl and 1 to 3 carbon atoms, which is an important intermediate in the synthesis of prostadienoic acid derivatives referred to as prostaglandins. High biological
234 514 účinnost táto skupiny látek jak v humánní, tak veterinární medicíně vyvolala jejich velmi Intensivní výzkum s cílem připravit je synteticky.234 514 The efficacy of this class of substances in both human and veterinary medicine has prompted their very intensive research to prepare them synthetically.
Nejvýznamnější mezi těmito postupy je syntéza zvaná horbornadienová, což znamená, že výchozí látkou je norbornadien. Některá modifikace jsou popsány v J. Ámer. Chem. Soc 22, 7522 /1973/, J. Chem. Soo. Chem. Commun. 1974. 151, J. Org. Chem. £2, 786 /1977/ a US patentech č. 3 992 438 a 3 943 151. Do. táto skupiny patří také AO 202 478, kde je popsán způsob výroby halogeneeterů obecného vzorce IIThe most important of these is a synthesis called horbornadien, which means that the starting material is norbornadien. Some modifications are described in J.Amer. Chem. Soc. 22, 7522 (1973), J. Chem. Soo. Chem. Commun. 1974, 151, J. Org. Chem. 2, 786 (1977) and U.S. Patent Nos. 3,992,438 and 3,943,151. this group also includes AO 202 478, which describes a process for the preparation of the haloeeters of formula II
o kde X je Cl, Br nebo I a R je alkyl o 1 až 6 atomech uhlíku.wherein X is Cl, Br or I and R is alkyl of 1 to 6 carbon atoms.
Vynález řeší způsob převedení látek typu II na produkty I a to tak, že jednotlivá meziprodukty celého postupu se nemusí izolovat a převedení ee fakticky provádí jako jediná operace. Výhodou je taká skutečnost, že ee látky typu I velmi snadno čistí jedno duehou krystalizaoí z vody. Kyseliny typu I lze potom dále snadno převést na prostaglan diny s využitím čs. autorského osvědčeni č. (PV 2556-79).The invention solves a process for converting type II substances into products I in such a way that the individual intermediates of the whole process need not be isolated and the conversion is in fact carried out as a single operation. The advantage is that type I substances are very easy to purify by due to crystallization from water. The type I acids can then be easily converted to prostaglanines using MS. Certificate No. (PV 2556-79).
XX
Postup podle vynálezu řeší způsob výroby (3ac<,4fl ,5»<. ,6ac<)-hexahydro-5-aoyloxy-4-karboxy-2H-oyklopenta£b]furan-2-onu obeoaáho vzorce IThe process according to the invention solves a process for the preparation of (3a, 4a, 5a, 6aa) - hexahydro-5-aoyloxy-4-carboxy-2H-cyclopenta [b] furan-2-one of the formula I
kde R1 značí alkyl a 1 až 3 atomy uhlíku, spočívající v tom, že alkylester 5-halogen-2-kato-bicyklo[2,2,l]heptan-7-karboxylové kyseliny obecného vzorce ΪΙwherein R 1 is alkyl and 1 to 3 carbon atoms, characterized in that the 5-halo-2-catabicyclo [2.2.1] heptane-7-carboxylic acid alkyl ester of the formula
(II), p(II), p
kde R značí alkyl s 1 až 6 atomy uhlíku a X značí chlor, brom nebo jod, převede působením peroxokysellny nebo peroxidu vodíku, e výhodou roztoku kyseliny peroetové v dichlormethanu nebo diohlorethanu na £-lakton(5“halogen-3-hydroxy-2-alkyloxykarbonyl-cyklf'pent-l-yl)octové kyseliny obecného vzorce ΪΧΙ,where R is C 1 -C 6 alkyl and X is chlorine, bromine or iodine, converted by treatment with peroxyacid or hydrogen peroxide, preferably a solution of peracetic acid in dichloromethane or di-chloroethane, to? -lactone (5 "halo-3-hydroxy-2- alkyloxycarbonyl-cyclopent-1-yl) acetic acid of the general formula ΪΧΙ,
(III), p(III), p
kde R a X mají shora uvedený význam· Tento lakton v alkalickém prostředí podlehne hydrolýze esterové funkce, nuklaofilní substituci halogenu a otevření, <F-laktonového kruhu, čímž vznikne sůl (lt<,2/l,3í»£.,5o<)-(3,5-dÍhydroxy-2-kerbta:y-eyklopent‘'l-yl)oetové kyseliny obecného vzorce IV,where R and X are as defined above This lactone in an alkaline medium will succumb to hydrolysis of the ester function, the nuclophilic halogen substitution and the opening of the <F-lactone ring to form a salt (lt <1,2 / 1,3,5, 5o <). - (3,5-dihydroxy-2-kerbeta-y-cyclopent'-1-yl) acetic acid of formula IV,
OHOH
OH (IV), kde Me značí alkalický kov, které se bez izolace převede okyselením anorganickou nebo organickou kyselinou, s výhodou octovou, na (3ao6 ,4^> ,5*<,6β<30 )hexahydro-5-hydroxy-4-karboxy-2H-cyklopentaQf]furan-2-on vzorce V,OH (IV), where Me is an alkali metal which is converted without isolation by acidification with an inorganic or organic acid, preferably acetic acid, to (3aO6, 4 → 5, 5 *, 6β <30) hexahydro-5-hydroxy-4- carboxy-2H-cyclopenta [f] furan-2-one of formula V,
OH který se působením acylačního činidla, s výhodou přebytku acetylchloridu převede na kyselinu obecného vzorce I. Tato se izoluje po odstranění přebytku acylačního činidla přídavkem vody a odsátím. Analytický preparát ee získá krystalizací z vody.The OH is converted to an acid of formula I by treatment with an acylating agent, preferably an excess of acetyl chloride. This is isolated after removal of the excess acylating agent by addition of water and suction. The analytical preparation is obtained by crystallization from water.
Předmět vynálezu je doložen následujícími příklady, které nikterak neomezují jeho rozsah.The invention is illustrated by the following non-limiting examples.
Příklad 1 (3ao<,4^>,5t<.,6ac<)hexahydro-5-aeetoxy-4-karboxy-2H-cyklopanta[b2furan~2_on (Ϊ» = CH-j)Example 1 (3ao <4 ^> 5 t <., 6AC <) hexahydro-5-acetoxy-4-carboxy-2-cyklopanta [b2 ~ furan 2_on (Ϊ »= CH-j)
10,1 g esteru II (X=01, R2=CH^), bylo rozpuštěno v 100 ml dichloethenu a při 0 °G přidáno během 2 hodin 75 ml 1M roztoku peroctové kyseliny v dlchlorethanu. Směs byla poté ponechána při teplotě místnosti 72 hodin a nakonec zahřívána do ztráty reakce na přítomnost peroxidů. Směs byla za vakua odpařena k suchu a rozpuštěna v roztoku 6 g Nadi v 80 ml vody. Po 24 hodinách bylo pH směsi upraveno přídavkem kyseliny na 5-6.10.1 g of ester II (X = O 1 , R 2 = CH 2) was dissolved in 100 ml of dichloroethene and 75 ml of a 1M solution of peracetic acid in dichloroethane was added over 2 hours at 0 ° C. The mixture was then left at room temperature for 72 hours and finally heated until loss of reaction to the presence of peroxides. The mixture was evaporated to dryness in vacuo and dissolved in a solution of 6 g of Nadi in 80 ml of water. After 24 hours, the pH of the mixture was adjusted to 5-6 by addition of acid.
Směs bylá odpařená k suchu, což bylo ještě třikrát opakováno vždy s přídavkem 100 ml kyseliny octové a jednou se 100 ml toluenu. Ke zbytku bylo přidáno 80 ml acetylchloridu a vše bylo ponecháno při teplotě místnosti 12 hodin. Směs byla poté odpařena za vakua k suchu a přídavkem 20 ml vody byla kyselina sražena, odsáta a překrystalizována z 35 ml vody. Bylo získáno 5,7 g (50 %).The mixture was evaporated to dryness, which was repeated three more times with 100 ml of acetic acid each time and once with 100 ml of toluene. To the residue was added 80 mL of acetyl chloride and left at room temperature for 12 hours. The mixture was then evaporated to dryness in vacuo and acid was precipitated by addition of 20 ml of water, filtered off with suction and recrystallized from 35 ml of water. 5.7 g (50%) were obtained.
Příklad 2Example 2
Kyselina I (R^CH-j)Acid I (R ^CH CH)
Vycházejíce z 11,3 g esteru II (X=Br, R=CHj) bylo pracováno podle postupu z příkladu 1. Krystalizací bylo nakonec získáno 5,2 g (46 %) kyseliny.Starting from 11.3 g of ester II (X = Br, R = CH 3), the procedure of Example 1 was followed. Crystallization finally gave 5.2 g (46%) of the acid.
Příklad 3Example 3
Kyselina I (R^=CHj)Acid I (R ^ = CH3)
Vycházejíce z 16,1 g esteru II (X=l, R2= η-Ο^Η?) bylo pracováno podle postupu z příkladu 1. Krystalizací bylo získáno 3,6 g (32 $) kyseliny I.Starting from 16.1 g of ester II (X = 1, R 2 = η-Ο Ο Η Η), the procedure of Example 1 was followed. Crystallization gave 3.6 g (32 $) of acid I.
Příklad 4Example 4
Kyselina í (R^CH-j).Acid 1 (R CHCH CH).
11
Vycházejíce z 13,5 g esteru II (X=C1, R « n-C6Hii) bylo pracováno podle postupu z příkladu 1. Krystalizaci bylo získáno 5,1 g (45 %) kyseliny X.Starting from 13.5 g of ester II (X = Cl, RnC 6 H ii), the procedure of Example 1 was followed. Crystallization yielded 5.1 g (45%) of acid X.
Příklad 5Example 5
Kyselina I (R^CIŤj)Acid I (R ^ CH3)
Navážka podle příkladu 1, oxidace peroxosloučeninou a alkalická hydřolýza byly vSak spojeny do jediné operace tak, že výchozí ester byl při O ®C rozpuštěn v přebytku alkalického peroxidu vodíku. Po 72 hodinách byly peroxidy odstraněny a směs byla dále zpracována již zcela podle popisu v příkladu 1. Bylo získáno 19 9 kyseliny I.However, the portion of Example 1, peroxo compound oxidation and alkaline hydrolysis were combined in a single operation such that the starting ester was dissolved in an excess of alkaline hydrogen peroxide at 0 ° C. After 72 hours the peroxides were removed and the mixture was further processed as described in Example 1. 19 9 of acid I were obtained.
Příklad 6Example 6
Kyselina I (R^CH-j)Acid I (R ^CH CH)
Bylo pracováno zcela podle příkladu 1, pouze acetylace byla provedena účinkem acetanhydridu v pyridinu. Po zpracování bylo získáno 27 % kyseliny I.The procedure was carried out entirely according to Example 1, except that the acetylation was carried out with acetic anhydride in pyridine. After processing, 27% of acid I was obtained.
Příklad 7Example 7
Kyselina I (R^=n-C-jH^) , Bylo pracováno podle příkladu I, pouze v posledním stupni bylo přidáno 130 ml chloridu kyseliny máselné. Reakční směs byla potom zpracována již totožně s popisem příkladu 1 a bylo získáno 35 9 kyseliny I.Acid I (R ^ = n-C -H ^). The reaction was carried out according to Example I, but only 130 ml of butyric acid chloride were added in the last step. The reaction mixture was then worked up in the same manner as described in Example 1 and 359 of acid I were obtained.
Přiklad 8Example 8
Kyselina I (R^aCH^) g odparku z matečných louhů po krystalizaci laktonesteru XII (R”CH^, X=C1) bylo zá chladu rozpuštěno v roztoku 55 g KOH v 750 ml studené vody. Za 24 hodin byla směs zneutralizována při teplotě místnosti přídavkem iontoměniče v Η4* cyklu do pH 5 až 6. Po filtraci byla poté směs odpařena k suchu. Odparek byl třikrát odpařen za vakua s 200 ml kyselina octové a jednou s 200 ml toluenu. Ke zbytku bylo za chlazení přidáno 500 ml acetylchloridu a váe ponecháno při teplotě místnosti 12 hodin za občasného promíchání. Směs byla odpařena za vakua, načež bylo přidáno 100 ml studené vody. Vypadlá kyaálina byla překryatalizována z 200 ml vody, přičemž bylo získáno 30 g produktu 1 (36 %).Acid I (R ^ and CH ^) g of the mother liquor residue after crystallization of lactonester XII (R ”CH ^, X = Cl) was dissolved in a solution of 55 g of KOH in 750 ml of cold water. After 24 hours, the mixture was neutralized at room temperature by the addition of an ion exchanger in a Η 4 * cycle to pH 5-6. After filtration, the mixture was then evaporated to dryness. The residue was evaporated three times under vacuum with 200 ml of acetic acid and once with 200 ml of toluene. Acetyl chloride (500 ml) was added to the residue with cooling and left at room temperature for 12 hours with occasional stirring. The mixture was evaporated in vacuo and 100 mL of cold water was added. The resulting acid was recrystallized from 200 mL of water to give 30 g of product 1 (36%).
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS508980A CS214514B1 (en) | 1980-07-17 | 1980-07-17 | Method of making the /3a alpha,4beta,6a alpha/hexahydro-5-acyloxy-4-carboxy-2h-cyclopenta/b/ furran-2-on |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS508980A CS214514B1 (en) | 1980-07-17 | 1980-07-17 | Method of making the /3a alpha,4beta,6a alpha/hexahydro-5-acyloxy-4-carboxy-2h-cyclopenta/b/ furran-2-on |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS214514B1 true CS214514B1 (en) | 1982-04-09 |
Family
ID=5395075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS508980A CS214514B1 (en) | 1980-07-17 | 1980-07-17 | Method of making the /3a alpha,4beta,6a alpha/hexahydro-5-acyloxy-4-carboxy-2h-cyclopenta/b/ furran-2-on |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS214514B1 (en) |
-
1980
- 1980-07-17 CS CS508980A patent/CS214514B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6365657B2 (en) | ||
| SU620206A3 (en) | Method of obtaining oxime derivatives or salts thereof | |
| WO2013174848A2 (en) | Improved process for the preparation of treprostinil and derivatives thereof | |
| US4425273A (en) | Process for production of chenodeoxycholic acid | |
| US5344974A (en) | Process for the preparation of N-acyl derivatives of 5-aminolevulinic acid, as well as the hydrochloride of the free acid | |
| EP0729936A1 (en) | Process for the synthesis of alpha substituted acrylic acids and their application | |
| EP0150996A2 (en) | Manufacture of heptanoic acid derivatives | |
| CS214514B1 (en) | Method of making the /3a alpha,4beta,6a alpha/hexahydro-5-acyloxy-4-carboxy-2h-cyclopenta/b/ furran-2-on | |
| SU466684A3 (en) | Method for preparing 2-nitroimidazole derivatives | |
| FR2458556A1 (en) | PAROMOMYCIN DERIVATIVES, PROCESS FOR PREPARING THEM AND THEIR USE AS A MEDICINAL PRODUCT | |
| SU1277897A3 (en) | Method of producing 1,1-dioxo-6-brom(or-6,6-dibromine) penicillanoyloxymethyl ethers of 6-(2-azido-2-phenylacetamido)penicillanic acid | |
| RU2616974C1 (en) | METHOD OF PRODUCTION ω-(BIS(PYRIDINE-2-ILMETHYL)AMINO)ALIPHATIC ACIDS - PRECURSORS WITH HELATERAL CENTERS FOR BINDING METALS | |
| JPH0121146B2 (en) | ||
| Mager et al. | Activation and transfer of oxygen—XI: Autoxidative behaviour of some N1, 3, 5-methylated tetrahydrolumazines and dihydroalloxazines | |
| RU2024541C1 (en) | METHOD OF SYNTHESIS OF α,5- CYCLO -24R- METHYL -a- CHOLEST -7,22- DIENE-6b-OL | |
| US5073538A (en) | Cycloalkylidene derivatives and fragrance composition | |
| CS216027B1 (en) | Method of making the +l3a alpha,4beta,5alpha,6a alpha+phexahydro-5-acyloxy-4-carboxy-2h-cyclopenta+lb+pfuran-2-on | |
| JPH06239779A (en) | Production of optically active cyclopentenediol | |
| JPS6039278B2 (en) | steroid derivatives | |
| Elvidge et al. | S 30. Gliotoxin. Part I. Synthesis of 2-thio-3-methylindolo-1′: 2′–1: 5-hydantoin and its identification as a degradation product of gliotoxin | |
| SU950720A1 (en) | Process for producing 4-carboxy-2,2,5,5-tetramethyl-3-imidazoline-1-oxyl | |
| SU946404A3 (en) | Process for producing steroid (16 alpha 17 beta)cyclohexane- or naphthalene-21-carboxylic acids or their esters | |
| BE818471A (en) | PROCESS FOR PREPARING 1-ARALKYL-4-AMINO-METHYLPIPERIDINE-4-OLS | |
| SU1641829A1 (en) | Method of producing cholesterol ester of o-cumaric acid | |
| SU421186A3 (en) | Method of producing 17-aza-16-keto-steroids derivatives |